Quotes 5-day view End-of-day quote Korea Stock Exchange
01/15/2021
01/18/2021
01/19/2021
01/20/2021
01/21/2021
Date
153000
148000
148000
148000
151500
Last
253514
419631
274255
243971
641065
Volume
-1.29% -3.27% 0.00% 0.00% +2.36% Change
Sales 2020
20,3 B 0,02 B 0,02 B
Net income 2020
-205 B -0,19 B -0,19 B
Net cash position 2020
389 B 0,35 B 0,35 B
P/E ratio 2020
-54,6x
Yield 2020
-
Sales 2021
181 B 0,16 B 0,16 B
Net income 2021
-140 B -0,13 B -0,13 B
Net cash position 2021
234 B 0,21 B 0,21 B
P/E ratio 2021
-118x
Yield 2021
-
Capitalization
11 864 B 10 785 M 10 761 M
EV / Sales 2020
584 135x
EV / Sales 2021
65 663x
Nbr of Employees
-
Free-Float
21,9%
SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.
All news about SK BIOPHARMACEUTICALS CO., LTD.
News in other languages on SK BIOPHARMACEUTICALS CO., LTD.
- No features available -
BTS manager Big Hit takes a beating as stock loses more than a fifth
Chart SK BIOPHARMACEUTICALS CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SK BIOPHARMACEUTICALS CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
6
Average target price
141 333,33 KRW
Last Close Price
151 500,00 KRW
Spread / Highest target
22,1%
Spread / Average Target
-6,71%
Spread / Lowest Target
-34,0%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
